Key result
Pretreatment with nortriptyline attenuated and delayed the acute antifibrillatory effect of bretylium, with ventricular fibrillation threshold reaching 25.2 mA at 90 min compared to 45.1 mA with saline.
Why the study?
Does pretreatment with nortriptyline attenuate the antifibrillatory effect of bretylium in pentobarbital anesthetized dogs?
Does pretreatment with nortriptyline attenuate the antifibrillatory effect of bretylium in pentobarbital anesthetized dogs?
Pretreatment with nortriptyline attenuates and delays the acute antifibrillatory effect of bretylium, suggesting that cardiac adrenergic neurons are a key target for its beneficial effects.
Answers are grounded in this paper and cite their sources.
Alerts to potential nortriptyline-bretylium interaction in VF-prone patients; leaves open translation of adrenergic mechanism to humans.
This study was performed to assess the role of cardiac sympathetic nerves in the in vivo antifibrillatory action of bretylium using the technique of electrically induced ventricular fibrillation. An initial study determined that 3 mg/kg of nortriptyline, an adrenergic amine uptake inhibitor, was sufficient to prevent the adrenergic neuron blockade produced by 5 mg/kg of bretylium in pentobarbital anesthetized dogs. Electrical ventricular fibrillation threshold (VFT) was then determined in two groups of pentobarbital anesthetized dogs using gated trains of increasing current applied to the epicardial surface of the right ventricle during atrial pacing. After determination of an initial VFT in both groups, one group of dogs (n = 8) received 3 mg/kg nortriptyline, the other group received saline (n = 9). The VFT was redetermined in both groups, after which all dogs received 5 mg/kg of bretylium, intravenously, and VFT was then measured at 15 and 90 min after bretylium. In saline-treated dogs, bretylium produced a significant increase in VFT from a control value of 6.9 +/- 1.6 mA (mean +/- SEM) to 31.0 +/- 0.5 mA at 15 min (p less than 0.05) and 45.1 +/- 4.8 mA at 90 min (p less than 0.05). In nortriptyline-treated dogs, however, nortriptyline itself produced an increase in VFT which was reversed by bretylium, and VFT after bretylium was not significantly elevated until 90 min to a value of 25.2 +/- 9.6 mA (control: 5.2 +/- 0.9 mA). These data demonstrate that pretreatment with nortriptyline attenuates and delays the onset of the acute antifibrillatory effect of bretylium and suggests a role for the cardiac adrenergic neuron as a potential target for part of the beneficial effects to be derived from antifibrillatory drugs.
No takes yet. Share an insight, caveat, or question.
Kopia et al. (2008) studied Ventricular fibrillation (n=17). Nortriptyline pretreatment followed by bretylium vs. Saline pretreatment followed by bretylium was evaluated on Electrical ventricular fibrillation threshold (VFT) (p=<0.05). Pretreatment with nortriptyline attenuated and delayed the acute antifibrillatory effect of bretylium, with ventricular fibrillation threshold reaching 25.2 mA at 90 min compared to 45.1 mA with saline.
Synapse has enriched 10 related papers. Consider them for comparative context: